My expertise is in the treatment of genitourinary tumors — particularly bladder and testicular cancers.In addition to treating patients, I have researched new drugs (and combinations of drugs) for people who have developed advanced bladder cancer and other genitourinary malignancies. My research has been directed toward improving treatment with chemotherapy, targeted drugs, and novel immunotherapy drugs; evaluating biological characteristics of tumors to predict treatment response; and understanding the genetic basis for both treatment response and development of urothelial cancers.
I am proud to have received a number of honors and awards for my work, including the MSK’s Willet Whitmore Award for Excellence in Patient Care and the ASCO Statesmen Award, which recognizes certain members for more than 20 years of extraordinary volunteer service, dedication, and commitment. Among other contributions, I also helped ASCO shape a new strategic plan to address the looming shortage of oncologists in the United States by 2020 — including the development of innovative practice arrangements.